Abstract
The aim of the study was to describe the occurrence of anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) in systemic sclerosis (SSc) patients. SSc patients who developed biopsy-proven AAV were identified. Their clinical manifestations, autoantibodies, presentation with vasculitis, treatment and outcome were described and compared with previously reported patients with these two conditions. Of 985 patients, 3 were identified. All patients had interstitial lung disease, and all presented with acute renal failure, proteinuria and hematuria, and were P-ANCA- and anti-Scl-70-positive. One required hemodialysis. Two were hypertensive; additionally, one patient had sinusitis, and another had monoarthritis and a macular rash. All were treated with high-dose corticosteroids and responded to therapy and attained remission at 6 months. At 1 year, one patient died of pneumonia. ANCA-associated vasculitis is a rare but serious finding in SSc patients. Positive anti-Scl-70 antibody is found commonly in these patients. Different treatment modalities are effective. Serious infections can complicate therapy and lead to death.
Similar content being viewed by others
References
Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM (1998) Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 37(1):15–20
Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35(1):35–42
Steen VD (2003) Scleroderma renal crisis. Rheum Dis Clin North Am 29(2):315–333
Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23(5):581–590
Oddis CV, Eisenbeis CH Jr, Reidbord HE, Steen VD, Medsger TA Jr (1987) Vasculitis in systemic sclerosis: association with Sjogren’s syndrome and the CREST syndrome variant. J Rheumatol 14(5):942–948
Herrick AL, Oogarah PK, Freemont AJ, Marcuson R, Haeney M, Jayson MI (1994) Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 53(5):323–326
Choi HK, Merkel PA, Walker AM, Niles JL (2000) Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 43(2):405–413
Bonaci-Nikolic B, Nikolic MM, Andrejevic S, Zoric S, Bukilica M (2005) Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther 7(5):R1072–R1081
Culver B, Itkin A, Pischel K (2005) Case report and review of minocycline-induced cutaneous polyarteritis nodosa. Arthritis Rheum 53(3):468–470
Dobre M, Wish J, Negrea L (2009) Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. Ren Fail 31(8):745–748
Bienaime F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP (2007) D-penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 50(5):821–825
Nanke Y, Akama H, Terai C, Kamatani N (2000) Rapidly progressive glomerulonephritis with D-penicillamine. Am J Med Sci 320(6):398–402
Hillis GS, Khan IH, Simpson JG, Rees AJ (1997) Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kidney Dis 30(2):279–281
Karpinski J, Jothy S, Radoux V, Levy M, Baran D (1997) D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 17(6):528–532
Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873
Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R, Tanaka H et al (1997) Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies—related scleroderma renal crisis treated with double-filtration plasmapheresis. Intern Med (Tokyo, Japan) 36(7):508–513
Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, Schlondorff D (1999) MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am J Kidney Dis 33(4):e3
Wutzl AL, Foley RN, O’Driscoll BR, Reeve RS, Chisholm R, Herrick AL (2001) Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Rheum 45(6):533–536
Endo H, Hosono T, Kondo H (1994) Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21(5):864–870
Rho YH, Choi SJ, Lee YH, Ji JD, Song GG (2006) Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int 26(5):369–375
Kao L, Weyand C (2010) Vasculitis in systemic sclerosis. Int J Rheumatol :385938
Negi VS, Tripathy NK, Misra R, Nityanand S (1998) Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 25(3):462–466
Ihn H, Sato S, Fujimoto M, Igarashi A, Yazawa N, Kubo M et al (2000) Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin Exp Immunol 119(1):203–209
Yu F, Zhao MH, Zhang Y, Zhang YK (2005) Anti-endothelial cell antibodies(AECA) are associated with disease activity of propylthiouracil induced antineutrophil cytoplasmic antibody (ANCA) positive vasculitis. Beijing da xue xue bao Yi xue ban=J Peking Univ 37(4):374–377
Holmen C, Christensson M, Pettersson E, Bratt J, Stjarne P, Karrar A et al (2004) Wegener’s granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 66(3):1049–1060
Carvalho D, Savage CO, Isenberg D, Pearson JD (1999) IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42(4):631–640
Carvalho D, Savage CO, Black CM, Pearson JD (1996) IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Investig 97(1):111–119
Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68(3):310–317
Author information
Authors and Affiliations
Corresponding author
Additional information
Source of support
Dr. Sindhu Johnson has been awarded a Canadian Institutes of Health Research Clinician Scientist Award and is supported by the Norton-Evans Fund for Scleroderma Research.
Rights and permissions
About this article
Cite this article
Omair, M.A., Mohamed, N., Johnson, S.R. et al. ANCA-associated vasculitis in systemic sclerosis report of 3 cases. Rheumatol Int 33, 139–143 (2013). https://doi.org/10.1007/s00296-011-2359-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2359-z